Patient perspective: Is intensive screening of women at high risk of breast cancer evidence-based medicine or ?
In 2023, a breast cancer risk assessment and a subsequent positive test for the BRCA-2 genetic mutation brought me to the uncomfortable intersection of a longstanding career as an advocate for high-quality medical evidence to support shared patient-provider decision making and a new role as a high-r...
Saved in:
Main Author: | Kathleen A Fairman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Women's Health |
Online Access: | https://doi.org/10.1177/17455057241307089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of breast cancer in higher-risk Taiwanese women using contrast-enhanced mammography
by: Chen-Pin Chou, et al.
Published: (2025-01-01) -
Suitable breast cancer screening strategy for Chinese women
by: CAO Xi, LUO Yongchao, SHEN Songjie
Published: (2024-09-01) -
High-intensity focused ultrasonic ablation of breast cancer
by: L. I. Moskvicheva
Published: (2018-09-01) -
Improving Breast Cancer Outcomes among Women in China: Practices, Knowledge, and Attitudes Related to Breast Cancer Screening
by: Tsu-Yin Wu, et al.
Published: (2012-01-01) -
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
by: Jill Tinmouth, et al.
Published: (2016-01-01)